Researchers are beginning the largest coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men. The $26.5 million study is called RESPOND, or Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Tumor Markers, and Social Stress. It will investigate environmental and genetic… Continue reading Comprehensive Study Launched on Aggressive Prostate Cancer in African-American Men
Tag: prostate cancer
Prostate Cancer DNA Test Identifies Men with Six-Fold Increased Risk
A major new study of more than 140,000 men has identified 63 new genetic variations in the DNA code that increase the risk of prostate cancer. Researchers devised a new test combining these single letter genetic variants with more than 100 others previously linked to prostate cancer to predict which men were most at risk… Continue reading Prostate Cancer DNA Test Identifies Men with Six-Fold Increased Risk
How to Fight the Side Effects of Hormone Therapy for Prostate Cancer
Men on hormone therapy for prostate cancer may benefit significantly from hitting the gym with fellow patients and choosing more veggies and fewer cheeseburgers, a study done at Ohio State University suggests. A release from the university explains that androgen deprivation therapy is a powerful tool against prostate cancer, and more and more men are… Continue reading How to Fight the Side Effects of Hormone Therapy for Prostate Cancer
Taking a Standard Prostate Cancer Drug with Food Boosts Impact and Lowers Cost
Abiraterone acetate, marketed as Zytiga®, is the standard medicine used to treat metastatic castration-resistant prostate cancer. Patients taking Zytiga are told to take four of the 250 milligram pills first thing in the morning on an empty stomach and then . wait at least one more hour before eating breakfast. However, by taking this high-cost… Continue reading Taking a Standard Prostate Cancer Drug with Food Boosts Impact and Lowers Cost
New Prostate Cancer Risk Model Could Be a Better Guide for Treatment
One of the biggest challenges in treating prostate cancer is distinguishing men who have aggressive and potentially lethal disease from men whose cancer is slow-growing and unlikely to metastasize. For years, prostate-specific antigen (PSA) level, cancer grade and tumor stage have been used to sort prostate cancer patients into risk groups established by the National… Continue reading New Prostate Cancer Risk Model Could Be a Better Guide for Treatment
Genetic counseling and Testing for Hereditary Prostate Cancer
There have been few recommendations to guide physicians about when to offer men genetic consultation for prostate cancer risk. Now, an international and inter-specialty panel of experts convened at the Sidney Kimmel Cancer Center (SKCC) at Thomas Jefferson University have developed a comprehensive set of recommendations. This consensus statement, published December 13th 2017 in the… Continue reading Genetic counseling and Testing for Hereditary Prostate Cancer
Prostate Cancer: Symptoms, Tests and Treatments
Here, an update from the federal Food and Drug Administration (FDA) about an all-too-widespread cancer among men. Prostate cancer is the most common cancer among men and the second most common cause of cancer-related deaths among American men. African-American men are more likely to get prostate cancer and twice as likely to die from the… Continue reading Prostate Cancer: Symptoms, Tests and Treatments
Why Advanced Prostate Cancer Resists Treatment
Metastatic prostate cancer, or prostate cancer that has spread to other organs, is incurable. Now, researchers have identified “gatekeeper genes” that allow the cancer to spread and resist treatment. The finding, published in the journal Science, was made by Roswell Park Cancer Institute investigators. The discovery showed how prostate cancer comes to evade therapy, and… Continue reading Why Advanced Prostate Cancer Resists Treatment
A Prostate-Cancer Treatment May Be Linked to Dementia
Prostate-cancer patients who are treated with testosterone-lowering drugs may be twice as likely to develop dementia within five years as those whose testosterone levels are not treated, according to a new study. The research, conducted at the Stanford University School of Medicine and the University of Pennsylvania Perelman School of Medicine, also demonstrates emerging techniques… Continue reading A Prostate-Cancer Treatment May Be Linked to Dementia
Guidelines Have Little Effect on Prostate-Cancer Screenings
Although health officials have published controversial prostate cancer screening guidelines, the guidelines didn’t significant change the number of screenings given to men, according to an extensive review by researchers at UT Southwestern Medical Center. The study, published in the journal Cancer, covered more than 275,000 visits at the facility. Revised guidelines from the United States… Continue reading Guidelines Have Little Effect on Prostate-Cancer Screenings
Monitoring Prostate Cancer Offers the Same Survival Chance as Surgery or Radiotherapy
Active monitoring of prostate cancer is as effective as surgery and radiotherapy in terms of survival at 10 years, reports the largest study of its kind, funded by the National Institute for Health Research (NIHR) in the UK. Results published in the New England Journal of Medicine in 2016 show that all three treatments result… Continue reading Monitoring Prostate Cancer Offers the Same Survival Chance as Surgery or Radiotherapy
Radiation Just as Good as Surgery for Aggressive Prostate Cancer
In cases of aggressive prostate cancer, high-dose radiation is just as effective as surgery, according to a new study by researchers at the UCLA Jonsson Comprehensive Cancer Center. The study also suggests that a particular form of radiation therapy, consisting of external radiation followed by brachytherapy (a type of radiation treatment in which a radioactive… Continue reading Radiation Just as Good as Surgery for Aggressive Prostate Cancer
Metastatic Prostate Cancer Cases Skyrocket
The number of new cases of metastatic prostate cancer climbed 72 percent in the past decade from 2004 to 2013, according to a Northwestern Medicine study published July 19th 2016 in Prostate Cancer and Prostatic Diseases. The report considers whether a recent trend of fewer men being screened may be contributing to the rise, or… Continue reading Metastatic Prostate Cancer Cases Skyrocket
Mindfulness Meditation Reduces Active Surveillance Anxiety in Prostate Cancer
Men with prostate cancer who are under close medical surveillance reported significantly greater resilience and less anxiety over time after receiving an intervention of mindfulness meditation, according to a pilot study from the Northwestern University Feinberg School of Medicine published in May 2016. Release from the university notes that the anxiety and uncertainty that men… Continue reading Mindfulness Meditation Reduces Active Surveillance Anxiety in Prostate Cancer
Low T? No Worries! Therapy Won’t Raise the Risk of Prostate Cancer.
Men with low levels of the male sex hormone testosterone need not fear that testosterone replacement therapy will increase their risk of prostate cancer. This is the finding of an analysis of more than a quarter-million medical records of mostly white men in Sweden. The research was led by investigators at New York University Langone… Continue reading Low T? No Worries! Therapy Won’t Raise the Risk of Prostate Cancer.
Low Vitamin D Levels Linked to Aggressive Prostate Cancer
Low levels of Vitamin D appear to be linked to aggressive prostate cancer, according to new research. The finding, by Northwestern Medicine researchers, is important because it can offer guidance to men and their doctors who may be considering active surveillance, in which they monitor the cancer rather than remove the prostate. “Vitamin D deficiency… Continue reading Low Vitamin D Levels Linked to Aggressive Prostate Cancer
Older People May Be Getting Cancer Screenings That Are Not Recommended
An estimated 15.7 percent of people 65 or older may have received screenings for prostate and breast cancers that were not recommended because the patients had limited life expectancies of less than 10 years, according to an article published online in January 2016 by JAMA Oncology. A release from the publishers notes that existing guidelines… Continue reading Older People May Be Getting Cancer Screenings That Are Not Recommended
More Targeted Treatment for Advanced Prostate Cancer
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have pinpointed five specific enzymes (protein kinases) that play a role when prostate cancer spreads to bone. The discovery could point the way toward new drugs that slow or stop prostate cancer from spreading. The findings, which were published… Continue reading More Targeted Treatment for Advanced Prostate Cancer